Symmetrical dyschromatosis of extremities
|
0.010 |
Biomarker
|
disease |
BEFREE |
The adenosine deaminase acting on RNA 1 p150 isoform is involved in the pathogenesis of dyschromatosis symmetrica hereditaria.
|
23621630 |
2013 |
Metabolic Syndrome X
|
0.010 |
Biomarker
|
disease |
BEFREE |
On depletion of Vps15, the metabolic syndrome in genetic and diet-induced models of insulin resistance and diabetes is alleviated.
|
26387534 |
2015 |
Glycogen Storage Disease Type IIb
|
0.010 |
Biomarker
|
disease |
BEFREE |
Both DD and GSDII show accumulation and altered localization of VPS15 in autophagy-incompetent fibers.
|
28102838 |
2017 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Deregulation of chromatin assembly factor 1, p150 subunit A (CHAF1A) has recently been reported to be involved in the development of some cancer types.
|
24845563 |
2014 |
CML progression
|
0.010 |
Biomarker
|
disease |
BEFREE |
In this study, whole-transcriptome sequencing of normal, chronic phase, and serially transplantable blast crisis chronic myeloid leukemia (CML) progenitors revealed increased IFN-γ pathway gene expression in concert with BCR-ABL amplification, enhanced expression of the IFN-responsive ADAR1 p150 isoform, and a propensity for increased adenosine-to-inosine RNA editing during CML progression.
|
23275297 |
2013 |
Warburg Sjo Fledelius syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Recently mutations in the catalytic subunit p130 and the noncatalytic subunit p150 of Rab3 GTPase-activating protein were found to cause Warburg Micro syndrome and Martsolf syndrome, respectively, both of which exhibit mental retardation.
|
18413245 |
2008 |
Episodic Kinesigenic Dyskinesia 1
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results suggested that Vps15 was critical to the protective autophagy in HUVECs induced by AngII, and PDK1/PKC signaling pathway was probably involved.
|
31356904 |
2019 |
Ovarian Carcinoma
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
The P2 promoter is CpG-rich and susceptible to methylation silencing. p150 expression was restored in OVCA cell lines following growth in the presence of 5-azacytidine.
|
23273547 |
2013 |
Malignant neoplasm of ovary
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
The P2 promoter is CpG-rich and susceptible to methylation silencing. p150 expression was restored in OVCA cell lines following growth in the presence of 5-azacytidine.
|
23273547 |
2013 |
Carcinoma, Ovarian Epithelial
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
The P2 promoter is CpG-rich and susceptible to methylation silencing. p150 expression was restored in OVCA cell lines following growth in the presence of 5-azacytidine.
|
23273547 |
2013 |
Neoplasm Metastasis
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Furthermore, high p150 expression was more frequently seen in tumors at early invasive stages (p < 0.005), in tumors without metastases (both local and distant, p < 0.005) and in early TNM stages (p < 0.005) in general.
|
15382063 |
2004 |
Congenital arteriovenous malformation
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Thus, the activity of the Vps34/Vps15 complex is critical in disease conditions such as AVMs, and possibly a variety of other lysosomal storage diseases.
|
23630012 |
2013 |
Blast Phase
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, whole-transcriptome sequencing of normal, chronic phase, and serially transplantable blast crisis chronic myeloid leukemia (CML) progenitors revealed increased IFN-γ pathway gene expression in concert with BCR-ABL amplification, enhanced expression of the IFN-responsive ADAR1 p150 isoform, and a propensity for increased adenosine-to-inosine RNA editing during CML progression.
|
23275297 |
2013 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Statistical analysis revealed a close association between p150 overexpression and the clinicopathologic parameters of gastric cancer.
|
15382063 |
2004 |
Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Furthermore, high p150 expression was more frequently seen in tumors at early invasive stages (p < 0.005), in tumors without metastases (both local and distant, p < 0.005) and in early TNM stages (p < 0.005) in general.
|
15382063 |
2004 |
Squamous cell carcinoma of tongue
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The immunohistochemical expression of the p60 and p150 subunits of CAF-1 were evaluated in a series of SCCs of the tongue.
|
17543081 |
2007 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Statistical analysis revealed a close association between p150 overexpression and the clinicopathologic parameters of gastric cancer.
|
15382063 |
2004 |
Secondary Neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Furthermore, high p150 expression was more frequently seen in tumors at early invasive stages (p < 0.005), in tumors without metastases (both local and distant, p < 0.005) and in early TNM stages (p < 0.005) in general.
|
15382063 |
2004 |